BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Wolff-Parkinson-White Syndrome Reports From BioPortfolio:

Market Research Reports / Management Reports / Research Reports

Results from other life science and pharmaceutical sites:

Non-pharmacological Treatment of Atrial Fibrillation
Atrial fibrillation in patients with Wolf-Parkinson-White-syndrome may be dangerous, ... Research has partly aimed at developing a catheter-based "Maze-
like" ... they report favourable results in 70% of the patients, with
considerably less .... This pure atrial defibrillator was, however, withdrawn
from the market ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569901/...

Diltiazem: Drug Information Provided by Lexi-Comp: Merck Manual ...
26 Oct 2004 ... Wolff-Parkinson-White syndrome); ventricular tachycardia (with .... Exceptions: Azithromycin; Dirithromycin [Off Market]; Spiramycin. ..... A Report
of the American College of Cardiology Foundation Task Force on Clinical ... The
Multicenter Diltiazem Postinfarction Trial Research Group,” N Engl ...
http://www.merck.com/mmpe/print/lexicomp/diltiazem.html...

Therapy for the Brugada Syndrome
Masonic Medical Research Laboratory, 2150 Bleecker Street, Utica NY, 13501, ..... The gender distinction is not seen in all families; a recent report
describes a .... The only agent on the market in the United States with
significant Ito ..... M. Wolff-Parkinson-White syndrome associated with Brugada
syndrome. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474239/...

DailyMed: About DailyMed
Angina Pectoris: There have been reports of exacerbation of angina and, in some cases, ..... Beta-adrenergic blockade in patients with Wolf-Parkinson-White
syndrome and .... Research Triangle Park, NC 27709. By: Eurand America, Inc. ...
Marketing Category, Application Number or Monograph Citation, Marketing Start
...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=11330...

Squill (Urginea maritima, Scilla maritima)
The drug was removed from the market in 1975 after 15 reports of pseudolupus ... thoracic aortic aneurysm, or Wolff-Parkinson-White syndrome (7). .... Results
are promising; however more clinical research is needed in order to determine
...
http://www.naturalstandard.com/monographs/herbssupplements/s...

Fellowship Training Program
Other areas of research interest include cardiac epidemiology, outcomes and .... in a Young Patient with Occult Wolff-Parkinson-White Syndrome. ... Post-Market
Surveillance for Cardiovascular Devices:A Comprehensive Approach. ... Oncology
Reports, Special Issue on Computational Analysis and Decision Support Systems
...
http://www.dartmouth.edu/~cardio/fellowship/general.html...

Squill (Urginea maritima, Scilla maritima)
The below doses are based on scientific research, publications, traditional use, or expert opinion. ... Venocuran® was taken off of the market in 1975 and it is
not clear whether it ... thoracic aortic aneurysm, or Wolff-Parkinson-White
syndrome. ... The interactions listed below are based on reports in scientific
...
http://www.naturalstandard.com/monographs/herbssupplements/p...

Migraine Headache Misconceptions: Barriers to Effective Care: The ...
... Tolerability of sumatriptan: clinical trials and post-marketing experience. ... A report of the American College of Cardiology/American Heart Association
.... Health outcomes research. Available from www.reillyassociates.net. ... 1
subject with Wolf-Parkinson-White syndrome experienced tachycardia 30 min after
...
http://www.medscape.com/viewarticle/478604_2...

FDA Public Meeting August 2, 2007 Essential Use Designation ...
11 Jul 2007 ... what I will do if Maxair is removed from the market, .... “I am an asthma sufferer who also has Wolf Parkinson White's Syndrome, a ... Rx Data Confirm
Patient Reports. • Verispan Data, June 1, 2006 through May 31, 2007 .....
Associate Director, The Asthma Research Center, Brigham and Women's ...
http://www.fda.gov/downloads/Drugs/ResourcesForYou/ucm080611...

Migraine Headache Misconceptions: Barriers to Effective Care ...
Published reports and real-world experiences illustrate that these drugs do not merit fears of .... of sumatriptan: clinical trials and post-marketing
experience. .... Health outcomes research. Available from www.reillyassociates.
net. ... 1 subject with Wolf-Parkinson-White syndrome experienced tachycardia 30
min ...
http://www.medscape.com/viewarticle/478604...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.